Monogram Technologies Inc.
MGRMHealthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY24 | FY23 | FY22 | |
|---|---|---|---|
| Revenue | — | $365,000 | — |
| Operating income | −$15.3M | −$17.3M | −$10.6M |
| Net income | −$16.3M | −$13.7M | −$13.7M |
| Total assets | $17.8M | $16.6M | $13.7M |
| Total liabilities | $3.3M | $3.2M | $9.5M |
| Equity | $14.5M | $13.4M | $4.1M |
| EPS (diluted) | $-0.51 | $-0.61 | $-1.42 |
| Shares out. | 31.6M | 31.3M | 9.7M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2024- Operating margin
- —
- Net margin
- —
- Return on equity
- −112.6%
- Return on assets
- −91.9%
- Return on capital (ROCE)
- −94.3%
- Liabilities / assets
- 18.4%
- Debt / equity
- 0.23×
- Book value / share
- $0.46
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2024- Altman Z″ (distress)
- -8.16distress
- Accruals / assets
- −13.3%clean
- Piotroski F-Score
- 3/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 1 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Aug 15, 2025
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2024
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Icahn School Of Medicine At Mount SinaiPassive (13G)Jul 18, 2025
- Zimmer Biomet Holdings, Inc.Activist (13D)Jul 15, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Unis DouglasDirector | Oct 7, 2025 | D | 3.5M | — |
| Shamaei KamranOfficer — See Remarks | Oct 7, 2025 | D | 2,926 | — |
| Sexson BenjaminOfficer — See Remarks | Oct 7, 2025 | D | 4.0M | — |
| Knape NoelOfficer — See Remarks | Oct 7, 2025 | D | 296,385 | — |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| Sep 30, 2025 | 140,529 | 1.2 | -12.9% |
| Sep 15, 2025 | 161,431 | 1.7 | +4.3% |
| Aug 29, 2025 | 154,761 | 1.6 | -26.1% |
| Aug 15, 2025 | 209,433 | 1.3 | -2.2% |
| Jul 31, 2025 | 214,133 | 1.0 | -32.3% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Other material eventOct 7, 2025
- Shareholder voteSep 30, 2025
- Other material eventSep 5, 2025
- Regulation FD disclosureAug 29, 2025
- Entered a material agreementAug 28, 2025
- Regulation FD disclosureJul 31, 2025
- Regulation FD disclosureJul 30, 2025
- Regulation FD disclosureJul 29, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- EFFECTNov 19, 2025
- EFFECTNov 19, 2025
- 15-12GOct 21, 2025
- 4OWNERSHIP DOCUMENTOct 14, 2025
- 4OWNERSHIP DOCUMENTOct 14, 2025
- 3OWNERSHIP DOCUMENTOct 14, 2025
- S-8 POSOct 7, 2025
- POS AMOct 7, 2025
- POS AMOct 7, 2025
- 4OWNERSHIP DOCUMENTOct 7, 2025
- 4OWNERSHIP DOCUMENTOct 7, 2025
- 4OWNERSHIP DOCUMENTOct 7, 2025
- 4OWNERSHIP DOCUMENTOct 7, 2025
- 4OWNERSHIP DOCUMENTOct 7, 2025
- 4OWNERSHIP DOCUMENTOct 7, 2025
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.